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Abstract: Individual and group cardiac rehabilitation (CR) programs reduce cardiovascular morbidity
and mortality by reducing recurrent events, improving risk factors, aiding compliance with drug
treatment, and improving quality of life through physical activity and education. Home-based
programs are equally effective in improving exercise capacity, risk factors, mortality, and health-
related quality of life outcomes compared to hospital-based intervention. Cardio-telerehabilitation
(CTR) programs are a supplement or an alternative to hospital rehabilitation programs providing
similar benefits to usual hospital and home care. Despite this statement, implementation in the
public and private healthcare environment is still scarce and limited. The main objective of this
research was to evaluate the efficacy, feasibility, and adherence of a personalized eight-week mHealth
telerehabilitation program in low-risk cardiac patients in the hospital of Melilla (Spain). The secondary
aims were to investigate patient satisfaction, identify barriers of implementation and adverse events,
and assess cost-effectiveness from a health system perspective. A study protocol for a single center
prospective controlled trial was conducted at the Regional Hospital of Melilla (Spain), with a sample
size of (n = 30) patients with a diagnosis of low-risk CVD with class I heart failure according to
NYHA (New York Heart Association). Outcomes of this study, will add new evidence that could
support the use of CTR in cardiac patients clinical guidelines.
Keywords: telerehabilitation; physical therapy modalities; cardiovascular diseases; telemedicine;
cost-benefit analysis
1. Introduction
Effective secondary prevention programs have great potential to reduce the burden of
cardiovascular disease (CVD). The Global Burden of Disease (GBD) study, published in 2018,
revealed the worrying dimension of the CVD pandemic [1]. CVD caused one third of all
deaths in 2015, with an estimated prevalence of 422 million cases, predominantly atheroscle-
rotic, cardiovascular disease (coronary heart disease and stroke) [1]. In recent decades,
CVD mortality rates have fallen in developed regions. Improvements in cholesterol levels,
blood pressure and smoking are responsible for 44% of the decline, while 47% of the decline
is due to evidence-based medical care, therapies, and surgery [2]. The American Heart
Association (AHA), proposed and developed a new metric of ideal cardiovascular health
index as a means of assessing the cardiovascular health of a population, in what they called
“LS7” (Life simple seven). The system is based on the ideal values of seven cardiovascular
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risk factors and health behaviors, all of which are modifiable. The LS7 score includes seven
risk control factors, including three health factors (blood pressure BP, total cholesterol,
and blood glucose) and four health behavioral factors (body mass index (BMI), smoking,
physical activity, and diet) [3].
Individual and group cardiac rehabilitation (CR) programs, reduce cardiovascular
morbidity and mortality by reducing recurrent events, improving risk factors, aiding
compliance with drug treatment, and improving quality of life through physical activity
and education [4]. According to the clinical practice guidelines for stable cardiovascular
patients of the European Society of Cardiology (ESC), secondary prevention through a
cardiac rehabilitation program is highly recommended [4]. A recent Cochrane systematic
review with meta-analysis including 12 articles, concluded that home- and center-based
forms of cardiac rehabilitation seem to be equally effective in improving clinical and health
related quality of life outcomes in cardiac patients [5]. Unfortunately, despite these benefits
and recommendations, many heart patients do not participate in group or individual
cardiac rehabilitation (CR) programs. According to the EUROASPIRE questionnaire, only
44.8% of patients after a coronary event or revascularization stated that they had been
advised to attend CR programs, and of these, only 81.4% had attended CR programs (36.5%
of all patients) [6].
A recent systematic review collecting evidence published between 2001 and 2016
suggested that cardiac rehabilitation is cost-effective, especially with physical exercise as a
major component [7].
Moreover, economic evaluations of health interventions, provide important infor-
mation to health care providers, patients, planners, and politicians on the availability of
alternatives in the context of limited resources [8]. The World Health Organization (WHO)
recommends the use of the value-for-money threshold to identify the cost-effectiveness
of an intervention [9]. The American College of Cardiology (ACC) and the American
Heart Association (AHA) recommended a more recent guideline for the evaluation of
interventions in cardiac patients. This “value for money” for health is generally identified
as ‘very good’, ‘relatively good’, or ‘not good’ [10]. The absence of major differences in
the costs of a home versus hospital-based CR programs, as found in the 2015 Cochrane
review by Taylor et al., support the continued expansion of home cardiac rehabilitation
programs [11].
The European Society of Preventive Cardiology recommends the inclusion of cardiac
telerehabilitation (CTR) programs as novel intervention strategies. They identify CTR as a
supplement or an alternative to hospital programs [12]. Telerehabilitation (TR) programs
for patients with heart conditions provided similar benefits to usual hospital and home
care, with no adverse effects reported according to a recent systematic review in 2016 [13].
Telerehabilitation is a term used to describe the provision of rehabilitation services at a
distance, using communication technologies [14]. The Global Observatory for eHealth de-
fined mHealth or mobile health as medical and public health practice supported by mobile
devices, such as mobile phones, patient monitoring devices, personal digital assistants,
and other wireless devices [15]. Mobile technology also has the potential to overcome
barriers in performing cardiac rehabilitation monitoring, becoming a useful tool to promote
compliance. Studies have shown that the use of mobile health interventions has positive
benefits in increasing participation in rehabilitation [13].
Despite the fact that CTR has been shown to be as effective as CR in the hospital and
home environment in terms of exercise capacity and quality of life, to be cost-effective
and to improve patient satisfaction and adherence, its implementation in the public and
private healthcare environment is still scarce and limited [4,16,17]. Considering the current
health era and the large number of patients with cardiovascular diseases, it is advisable
to carry out feasibility, safety, and effectiveness studies in the implementation of cardiac
telerehabilitation programs both in the hospital environment and in other areas of care.
The aim of this research was to evaluate the efficacy, feasibility, and adherence of a
telerehabilitation program in low-risk cardiac patients in the hospital of Melilla (Spain).
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The secondary aims of this trial were to investigate patient satisfaction, to identify
barriers of implementation and adverse events, and to assess cost-effectiveness from a
health system perspective (costs of health interventions).
2. Material and Methods
This piece of research is a single center prospective controlled trial conducted at the
Regional Hospital of Melilla (Spain), which will facilitate voluntary participant recruitment
and the supervised CTR program component.
This research involves the departments of Cardiology, Rehabilitation, Physiotherapy,
and Research at the University of Granada. All CTR staff will receive training on how
to integrate the intervention training. As this study runs parallel to clinical practice,
all medical management, including medication prescription, will be at the discretion of the
treating physician. All changes will be documented and considered during analysis.
This research uses the guidelines on Standards for Quality Improvement and Excel-
lence in Reporting (SQUIRE) [18] and will be carried out in accordance with CONSORT
(Consolidated Standards of Reporting Trials) criteria [19]. A Standard Protocol Items Recom-
mendations for Interventional Trials (SPIRIT) checklist is provided as Supplementary File S1,
and the flow diagram for the study protocols is included as Figure 1.
2.1. Patients
The trial includes adults with a diagnosis of low-risk CVD with class I heart failure
according to the NYHA (New York Heart Association) functional assessment criteria (24),
diagnosed by the Cardiology and Rehabilitation team of the Hospital of Melilla. Patients
must live in Melilla during the intervention phase, have mobile technology with an internet
connection at home (including one of the following devices: desktop personal computer,
laptop, tablet, or smartphone), and be able to access email or instant messaging frequently
and reliably. Patients who suffered non-mild cardiac events prior to the first contact with
this research, those whose pathologies are not classified as CVD, and those subjects who
are not in full cognitive capacity that allows them to use new technology tools will be
excluded. Patients will be excluded if they have any absolute or relative contraindications
to exercise testing as per the American Heart Association guidelines [20]. Inclusion and
exclusion criteria is show in Table 1.
Table 1. Inclusion and exclusion criteria.
Inclusions Criteria Exclusions Criteria
Adult over 18 Years old Cognitive ability not suitable for the
use of technologic tools.Diagnosis: Ischemic heart disease in New York Heart
Association (NYHA) functional class I-II with preserved
global systolic function or in intermediate range
(LVEF > 40%) after revascularized acute
coronary syndrome.
Lives in Melilla during the research period. Absolute or relative contraindications
to exercise testingTo have mobile technology with an internet connection
at home (including one of the following devices: desktop
personal computer, laptop, tablet, or smartphone)
Ability and knowledge to access email or
instant messaging
Abbreviations LVEF, Left ventricular ejection Fraction.
In order to generate sufficient data for the development of this research, a sample size
of (n = 30) patients will be recruited. The primary aims of this sample size determination
is to evaluate whether the proposed intervention is feasible, safe, and effective. A larger
randomized controlled trial that would have adequate power could be designed based
on what was learned in this study. The strategies to achieve an adequate inclusion of
participants that reach the target sample size include the multidisciplinary collaboration
of the team from the Regional Hospital of Melilla (Cardiology Department, Head of the
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Rehabilitation Service and the Physiotherapy team). The collaborators were informed about
the characteristics of the study in personal interviews and presentation. We ensured that the
recruitment of patients has a socio-demographic diversity in relation to their social origin,
gender, ethnicity, and education adapted to the particularities of the reference population.
For the development of this research, an intentional non-probabilistic type of sampling will
be used for the convenience of the study, due to the characteristics of the subjects. This trial
has the approval of the Andalucía Ethics Committee with HIP version 17112020.
Figure 1. Study design. Abbreviations CVD, cardiovascular disease; CTR, cardio-telerehabilitation.
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2.2. Intervention
Participants are assigned to the cardiac telerehabilitation group to receive an initial
assessment. The CTR group receives a personalized 8-week exercise program through
a mHealth application that allows health professionals to generate videos, images, and
parameters of each exercise, as well as send them by email, instant messaging, and follow
up on patients. In this study, we use the Physiotec exercise prescription app as it allows
us to create personalized CTR programs according to particular clinical case and follow
their progress. The CTR program describes the exercises to be performed, the number
of repetitions according to the level of training and the criteria for progression. The CTR
program includes aerobic exercise at 60–85% of the maximum heart rate (HR) reached in
the ergometry test. As patients are taking β-blocker drugs, they will never reach their
maximum HR. Patients will be instructed in the use of the Modified Borg Scale to assess
their level of fatigue while performing the CTR program. Exercises customized to each
participant should be performed between values 4–6 on this scale (out of a maximum of 10).
The type of exercise can be continuous or intervallic (load or HR controlled):
Continuous Exercise: After an initial warm-up period of 5–10 min, the patient is
brought into a phase where he or she remains at a HR or resistance previously determined
by the intervention team.
Interval Exercise: After an initial warm-up period, an exercise is started which alter-
nates load peaks with lower intensity ones.
All patient training sessions should end with a return to the initial baseline situation
(relaxation phase) of similar duration to the warm-up phase 5–10 min.
Typical CTR training session:
- Control of basal constants (by the patient): HR, blood pressure, weight, blood sugar . . .
- Permanent monitoring during the whole CTR session (patient must understand and
follow the modified Borg scale as well as to use activity bracelets, pulse meters,
or other monitoring instruments)
- Exercise session:
◦ Initial warm-up: 5–10 min (follow-up the video exercises provided through
the CTR tool).
◦ Aerobic training: 35–45 min (follow up the video exercises provided through
the CTR tool)
◦ Return to calm, relaxation-cooling: 5–10 min (follow up of the video exercises
provided through the CTR tool)
◦ Recording of incidents and patient feedback in the CTR tool. Patient/physio-
therapist feedback
Patients are initially supervised by the research team who will conduct 1-to-1 training
sessions to ensure proper execution of the exercises and encourage patient adherence.
Patients are instructed to perform self-training by following the video exercises through the
CTR program. At the beginning of the study, advice is given on general care, in physical
activity and issues concerning drug intake.
Patients are advised to refrain from any other specific training during the intervention
period. Any deviations from the adherence and practice of the CTR program are recorded
daily, noting any adverse incidents.
The TR group receives a personalized program for 8 weeks, including at least one
session per day and is done through a web and mobile application. The telerehabilitation
application allows health professionals to create personalized exercise programs, hold
video conferences with patients, generate videos, images and parameters of each exercise,
as well as send them by email and follow up patients through the mobile application.
2.3. Outcome Measures
Affiliation Data and Socio-Demographic Questionnaire: including age, gender, loca-
tion, and other socio-demographic variables.
Int. J. Environ. Res. Public Health 2021, 18, 4038 6 of 11
2.3.1. Main Explanatory Variable
- Biochemical outcomes: obtained by blood analysis performed at the Hospital of
Melilla including the following measures: red blood cell levels, glucose, creatine
kinase (CK), triglycerides, cholesterol, high-density lipoprotein cholesterol (HDL-C),
low-density cholesterol (LDL-C), and glycosylated hemoglobin (HbA1c).
- Cardiac function: obtained by performing an ergometry test at the Hospital of Melilla,
including the following measurements: metabolic equivalent (MET), resting heart
rate (HRrest), maximum heart rate (HRmax), and final heart rate (HRfinal), rating
of perception of exertion scale (RPE), systolic blood pressure (SBP), diastolic blood
pressure (DBP).
- Quality of life: obtained through the completion of self-reported questionnaires with
the advice of the research team. The assessment of health-related quality of life will
be assessed by the following two questionnaires: SF-12 and EuroQoL-5d. The SF-12
questionnaire is the short version of the SF-36, containing twelve questions from
the SF-36. [21]. The SF-12 is an appropriate instrument of choice and is a practical
alternative for measuring the general health status of the population [22]. The SF-12
questionnaire assesses eight dimensions of health-related quality of life: physical
function, physical role, bodily pain, general health, vitality, social function, emotional
role, and mental health [21]. Two sum scores are also obtained for the physical health
component and the mental health component of the person. Thus, the sum index of
the physical and mental component corresponds to the overall idea of general health.
The EuroQoL-5D Questionnaire (EQ-5D) contains a descriptive system of one’s health
status measured in five dimensions (mobility, self-care, activities of daily living, pain,
and anxiety/depression) [23]. The EQ-5D has a visual analog scale (VAS) that assesses
health status “on the present day” with scores ranging from 0 (worst imaginable health
status) to 100 (best imaginable health status). The EQ-5D questionnaire provides
information on the level of the problem (no problem, somewhat/moderate problem
or severe problem) [24]. It has been shown to be a tool with an acceptable validity,
with an estimated mean of 0.87 [25].
- Functional capacity: For the assessment of functional capacity we will use the Duke
Activity Status Index (DASI). It is an assessment tool used to evaluate the functional
capacity of patients with cardiovascular disease, such as coronary artery disease,
myocardial infarction, and heart failure. It is a validated instrument and its Spanish
version is available [26,27]. The original version include 12 questions on aspects
of physical function related to activities of daily living. It allows a calculation of
functional capacity reporting results in ml of O2/kg/minute with good correlation
with peak VO2, and in turn can be compared with the METs [28].
2.3.2. Secondary Explanatory Variable
Satisfaction and usefulness: The acceptance and usefulness of telemedicine applica-
tions is a prerequisite for identifying the potential clinical benefits of this technology. It is
therefore important to complement this research with tools that examine patient satisfaction
and perception [29]. An adaptation of the Telemedicine Satisfaction and Usefulness Ques-
tionnaire (TSUQ), whose psychometric analysis supports construct validity and internal
consistency reliability, and which is available in English and Spanish, will be used [29].
The instrument used showed high reliability (Cronbach’s alpha 0.8) and evidence of valid-
ity with respect to perception in telemedicine [30]. It includes 17 questions that are assessed
with a 5-point Likert subjective scale (1 totally disagree and 5 completely agree). The
individual obtains scores from 17 to 85. The higher the score, the better the perception of
the telerehabilitation intervention. Therefore each of the scores of the 17 variables indicated
and finally the total score of the Test will be analyzed [29,30].
Analysis of the cost-effectiveness: To assess the cost-effectiveness of the telerehabilita-
tion intervention, the international guidelines for conducting cost analyses in randomized
clinical trials will be followed [31]. Such an economic analysis is based on the health
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sector perspective, which means that only costs corresponding to health interventions will
be considered, and not related costs to the patient. Therefore, only costs related to the
provision of health services will be taken into account [32].
Costs are divided into two categories of variables: firstly, costs related to clinical
aspects (direct costs) and secondly, costs related to the use of the technology (indirect costs).
Direct costs: Numerical variable calculated on the basis of the number of hours of
intervention and the cost of the physiotherapist according to the hourly wage in the health
system in the centers where the research is carried out. It will be calculated based on the
recording of the number of sessions in both groups.
Indirect costs: Numerical variable calculated based on the cost of using the technology
for the telerehabilitation platform.
Adherence and safety: Participants will be advised to report and record barriers of use
and any adverse event during the study. Number of sessions are automatically registered
by the CTR tool.
The Charlson Comorbidity Index (CCI) will be included in the demographic, anam-
nesis and medical history data [33]. CCI is a system for evaluating life expectancy at ten
years, depending on the age at which it is evaluated and the subject’s comorbidities.
We will try to ensure that the sample data are similar at baseline and there are no
significant differences in demographic, medical and other outcomes. The homogeneity
of the sample will be analyzed and normality tests will be performed. An outline of the
primary (4 dimensions) and secondary outcomes (3 dimensions) is shown at Table 2:




Hematies Level, Glucose, Creatine Kinase (CK),
Triglycerides, Total Cholesterol, High Density
Lipoprotein Cholesterol (HDL-C), Low Density




Metabolic Equivalent (MET), Resting Heart Rate
(RHR), Maximum Heart Rate (HRmax), Final
Heart Rate (FHR), Rating Scale for Perceived
Exertion (RPE), Systolic Blood Pressure (SBP),
Diastolic Blood Pressure (DBP)
Clinical
Quality of Life SF-12, EQ-5D Self-Reported
Functional Capacity Duke Activity Status Index (DASI) Self-Reported
Secondary Outcomes
Feasibility, Satisfaction and Usefulness Telemedicine Satisfaction and usefulnessQuestionaire (TSUQ) Self-Reported
Cost-Effectiveness Direct Costs/Indirect Costs €/Self-Reported
Adherence and Safety Nº of sessions completed and adverseevents record Automatized App record
2.4. Data Collection Procedure, Monitoring, and Management
Once participants have been informed and agree to participate in the study, data
will be collected for statistical analysis. This data collection will take place in the period
February–June 2021. Initial assessment (Pre) and final 8-week assessment (Post) will be
carried out by the research team with the cardiology, rehabilitation, and physiotherapy
departments. The data will be aggregated to a research database created for this purpose
and managed by the principal’s research using exportable data tables for statistical analysis.
The research is designed in 4 stages, as presented in Figure 1 in a study design
flow diagram:
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Stage 1 includes 2 different processes: firstly the identification of candidates, the
provision of prior information and the signing of informed consent in the event that the
subjects agree to participate. Secondly, the assessments by the cardiology department
with ergometry and biochemistry test at (T0-Pre). This stage ends with the referral to the
rehabilitation department.
Stage 2 includes: the assessments by the rehabilitation department with quality of
life, functional capacity outcomes, and comorbidity index added to previous clinical
information. At this stage, the Modified Borg Scale Education is offered to participants
to assess their level of fatigue during exercise. A personalized CTR program is proposed
according to the Physiotherapy Department. This stage ends with the referral to the
Physiotherapy department and CTR staff.
Stage 3 includes: 8 weeks CTR program with the supervision of the Physiotherapy
Department and the CTR staff. An initial 1-to-1 session is offered with technology manage-
ment and patient education. Daily follow up sessions include the progression, barriers of
use, and adverse event records. CTR team will updates programs according to participant’s
feedback and rehabilitation supervision.
Stage 4 includes: Final assessments and evaluation (T1-Post). At this stage, cardiology,
rehabilitation, physiotherapy and principal research are compiled into the results of clinical
and self-reported outcomes after 8 weeks CTR program including: biochemistry, ergometry,
quality of life, and functional capacity. At this stage, satisfaction and usefulness, economic
data safety, and adherence records will be added to research data’s for statistical analysis
2.5. Statistical Analysis
This research is a single center prospective controlled trial pre/post design. The results
of the trial research will be presented as a summary of the outcome measures, together
with the estimated effect size and precision. Statistical analysis will be performed accord-
ing to the intention-to-treat principle. Patient characteristics will be summarized using
frequencies and percentages for categorical factors, and using means and standard devia-
tions for continuous measures in order to have as much information as possible available
for exploration and analysis. The effect sizes will be calculated using Cohen’s d, so that
the results can be compared to other studies. The outcome measures will be compared
before and after the completion of the 8-week CTR program. All statistical analyses will be
conducted using SPSS software. Statistical significance was set at p < 0.05.
3. Results
Enrollment began in February 2021. First study results will be reported in the middle of
2021. Recruitment is currently underway. The recruitment goal is 30 cardiac rehabilitation
patients. Data collection is anticipated to be complete by July 2021.
If the results confirm beneficial effects in biochemical, cardiac function, quality of live,
and functional capacity, the effectiveness of the intervention will be proven in patients with
heart failure. The successful delivery of the intervention, the absence of significant adverse
effects, and the user satisfaction will demonstrate the feasibility of these interventions in
cardiac patients.
The results of this study will determine if a larger-scale intervention is feasible. Further,
this pilot study will be the first to examine the effect of CTR intervention on patients in a
cardiac rehabilitation setting in Melilla (Spain). The results of this study will provide differ-
ences compared to previous research: first of all, its implementation in the autonomous city
of Melilla (located on the African continent with particular demographic characteristics);
secondly the use of the innovative CTR platform based on the App Physiotec; thirdly, the
collection of outcomes that combine clinical, self-reported and economic data and lastly,
automated treatment adherence registry.
This study will add more evidence in support of the use of CTR program as an effective
tool in new cardiac rehabilitation programs.
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4. Discussion
Telemedicine has the promise of improving quality, increasing patient access, and
reducing health care costs [34], and recent advances in telecommunications technologies
have boosted the possibility of carrying out rehabilitation processes over the internet [35].
Studies have shown that telerehabilitation is effective in improving clinical outcomes in
various pathologies, suggesting that increasing the intensity provided by telerehabilitation
is a promising option to be offered to patients (32). This research should provide knowl-
edge about the possibility of implementing CTR programs in the hospital environment,
identifying the health resources and costs allocated to define new intervention policies
in this group of patients. Unlike other studies that require software implementations
in specific devices, our intervention generates few obstacles since it is available in any
device that allows internet connection and that patients usually have (PC, laptop, tablet,
smartphone), allowing access from any location and different devices prioritizing the use of
mobile health. This contrasts with other studies that require a highly complex technological
platform, software installation, and multidirectional cameras for controlled clinical control
connecting the healthcare provider and the patient [36].
Technical problems (disconnection, device failures) and technological difficulties may
arise in connection with the use of technology. However, staff members are available to
provide technical support by phone or email, without the need to visit the patient at home
to install or check any hardware. As possible adverse events, we considered the lack of
improvement and positive evolution of the patient as well as the appearance of a low level
of adherence. We also considered as an adverse event the performance of exercise with
excessive workload. Patients will be informed of the importance of warning the health
professional of any incident or setback in their recovery and their right to withdraw from
participation in the research at any time.
Future lines of research would involve the development of clinical trials with a large
sample size; a qualitative approach to attend focus groups to explore their thoughts and
concerns about the intervention. Themes will be constructed from the data to give insight
into the experiences of the different participant groups. As participation is important for
rehabilitation departments, it is essential to include the participants’ perspective in the
evaluation of the treatment. Finally, the opportunity to develop a multicenter randomized
clinical trial with comparison groups performing in-hospital or home-based rehabilitation
programs has the aim of identifying the most appropriate intervention.
5. Conclusions
This pilot study is the first to examine the effect of a CTR intervention on patients with
heart failure in a cardiac rehabilitation setting in the Hospital of Melilla (Spain). Efficacy,
feasibility, adherence, satisfaction, and cost-effectiveness must show if this study will add
more evidence in support of the use of CTR program as an effective tool in new cardiac
rehabilitation programs.
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